id,group_id,source,exact,prefix,suffix,anno_type,position_type,start,end,tags,all,origin_tags,comment,user,title,created
zpT5DKxFEemOCDcki8Zm8w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CRL4, kinase signaling by inhibiting ,"DCAF1, an E3 ubiquitin ligase of",TextQuoteSelector,TextPositionSelector,54745,54749,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:59:02.728421+00:00
zODlDqxEEem4xre9-d1R2A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CYR61,ine-rich angiogenic inducer 61 (,"), c-Myc, drosophila inhibitor o",TextQuoteSelector,TextPositionSelector,45259,45264,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:51:50.296756+00:00
z3QvTLQPEemKwJNEQUqmXQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC by blocking CUL4A nuclear export to ubiquitinate LATS1,"on, invasion, and metastasis of ", and increasing YAPS127 phosphor,TextQuoteSelector,TextPositionSelector,47734,47792,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:52:40.654277+00:00
xmLfkrRMEemeY99n_ctubQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,peroxidase, by incubation with horseradish , (HRP)-conjugated anti-DIG antib,TextQuoteSelector,TextPositionSelector,20093,20103,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:09:04.618265+00:00
xZtlCLQPEemx228excqwww,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CUL4A overexpression abrogated the uc.134-mediated repression HCC,l function analysis showed that , cell proliferation and invasion,TextQuoteSelector,TextPositionSelector,47433,47498,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:52:24.115332+00:00
xMUKWKxJEemVuf-zIJp5JQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,DICER1, triggers the ubiquitination of , in cytoplasm by CUL4A to promot,TextQuoteSelector,TextPositionSelector,40740,40746,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:27:24.230341+00:00
x0kyiqxFEemP_aNfZtfd5A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CRL4,", an E3 ubiquitin ligase of the ", complex [42]. CUL4A is a core c,TextQuoteSelector,TextPositionSelector,54786,54790,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:58:50.398126+00:00
wNvlvKxHEem4Pvdj1t9EMA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,hepatitis C virus infection,"virus (HBV) infection, although ", and exposure to toxic chemical ,TextQuoteSelector,TextPositionSelector,58504,58531,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:12:58.689121+00:00
wN9xaqxGEemRFTOFDyVSlA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,DICER," CUL4A including p53, p21, p27, ",", and LATS1 [32]. Previous studi",TextQuoteSelector,TextPositionSelector,40612,40617,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:05:49.027330+00:00
vVGP0LQPEem2DJ8IUuNa3Q,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CUL4A to overcome the uc.134-mediated activation of Hippo kinase signaling in HCC,We then assessed the ability of ," cells. Notably, Western blottin",TextQuoteSelector,TextPositionSelector,46987,47068,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:52:10.303772+00:00
vF9GgKxJEemibnedKNAAAA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,STAT3,n that inflammation-induced Jak-, signaling triggers the ubiquiti,TextQuoteSelector,TextPositionSelector,40693,40698,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:27:10.077686+00:00
v82bGqxIEem_dv9j9EUjtA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,polyubiquitin,eus to the cytoplasm to disrupt ," chains, which activates the Hip",TextQuoteSelector,TextPositionSelector,46510,46523,WT_GP,no,[WT_GP],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:20:06.268995+00:00
uruvjrRMEembLjP-95Ci9w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,horseradish,was detected by incubation with , peroxidase (HRP)-conjugated ant,TextQuoteSelector,TextPositionSelector,20081,20092,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:08:45.067521+00:00
uEkYgKxGEemgfZt4LKyoUQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Jak,"enin, PI3-kinase/AKT, Hedgehog, ","/Stat, and Notch pathways [40]. ",TextQuoteSelector,TextPositionSelector,54335,54338,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:05:34.878589+00:00
u4BBlqxFEemX7i8HILCDrg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,tumorigenesis,"Hippo pathway, which suppresses "," and stem cell differentiation, ",TextQuoteSelector,TextPositionSelector,42552,42565,WT_DS,yes,[WT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:58:30.786978+00:00
tO_3bqxEEem9CrN1j1tWIQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,lung metastasis,to the tail veins. We monitored , at 6 weeks to quantify lung col,TextQuoteSelector,TextPositionSelector,21992,22007,WT_DS,yes,[WT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:51:10.252762+00:00
tIJ9zrQPEemAarOrTtVD7w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC proliferation and metastasis via the uc.134-CUL4A,protein.LncRNA uc.134 represses ,-Hippo axisA Western blot analys,TextQuoteSelector,TextPositionSelector,46677,46730,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:51:55.413840+00:00
sn2EsKxJEem-eetlmq8p-w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,p27,"ed by CUL4A including p53, p21, ",", DICER, and LATS1 [32]. Previou",TextQuoteSelector,TextPositionSelector,40607,40610,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:26:53.329072+00:00
s2ozXqxFEemiYcujhz8u2A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,RNP,at uc.134 and CUL4A can form an , complex in vitro. Previous stud,TextQuoteSelector,TextPositionSelector,38081,38084,WT_GP,yes,[WT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:58:17.157442+00:00
rhuPEqxIEemRIrcFkL0zSg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,humans,hat are highly conserved across ,", mice, and rats, so-called ultr",TextQuoteSelector,TextPositionSelector,51801,51807,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:19:36.524178+00:00
rKf6zqxFEemRDnvzO62WTQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,cell invasion,tion of uc.134 markedly reduced , compared with control cells (Fi,TextQuoteSelector,TextPositionSelector,33997,34010,WT_DS,yes,[WT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:58:05.790134+00:00
rHH6LKxGEem-cd81COA-fg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Hippo,inhibited the activation of the , pathway by directly binding to ,TextQuoteSelector,TextPositionSelector,55144,55149,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:05:14.848728+00:00
q_M1QqxHEem-JMuAbk_4DA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Histone deacetylase 3,utes to the growth of HCC [20]. , (HDAC3) is involved in the supp,TextQuoteSelector,TextPositionSelector,58753,58774,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:12:23.652866+00:00
qZwCwqxJEemvvxeHDwRbLA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,p21,"tinated by CUL4A including p53, ",", p27, DICER, and LATS1 [32]. Pr",TextQuoteSelector,TextPositionSelector,40602,40605,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:26:38.480899+00:00
pmhiuKxIEem_dQ94QnLz7A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,rats,"served across humans, mice, and ",", so-called ultraconserved regio",TextQuoteSelector,TextPositionSelector,51819,51823,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:19:23.758693+00:00
pHSJkqxHEem4PBPbi2LEgA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HDAC3,CC [20]. Histone deacetylase 3 (,) is involved in the suppression,TextQuoteSelector,TextPositionSelector,58776,58781,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:12:11.021527+00:00
ou5QRqxFEemmvnMf2D1BAg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,rabbit,itted to Western blotting using , anti-LATS1 monoclonal antibody ,TextQuoteSelector,TextPositionSelector,26676,26682,CRT_OG,yes,[CRT_OG][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:57:49.532886+00:00
oJZqNrRMEemNnx_wa4jxLA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,nude mice, inoculated subcutaneously into ,", and the HCCLM3 cell line was e",TextQuoteSelector,TextPositionSelector,28570,28579,CRT_OG,yes,[CRT_OG][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:08:01.328474+00:00
oH6lYqxGEem9Dd_rV67blg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,E3 ligase,ch showed that uc.134 bound the , CUL4A. Protein domain mapping a,TextQuoteSelector,TextPositionSelector,55408,55417,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:04:54.976952+00:00
nrNDJqxIEemWzl-xJ22mGA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,carcinomas,and differentially expressed in ,". Here, we used lncRNA microarra",TextQuoteSelector,TextPositionSelector,51970,51980,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:19:10.977193+00:00
ne66MqxJEemqS09brRYk_A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,p53,biquitinated by CUL4A including ,", p21, p27, DICER, and LATS1 [32",TextQuoteSelector,TextPositionSelector,40597,40600,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:26:19.137489+00:00
mi6S0qxEEem2Hgc4fKdaMw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,BALB/c nude mice,ittee of Nanfang Hospital. Male ," (age, 4–6 weeks; Guangdong Medi",TextQuoteSelector,TextPositionSelector,21447,21463,WS_OG,no,WS_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:50:25.386730+00:00
m-qDHqxFEemHf_Nl1_H9Eg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,MEG3,"e degradation of NF90 [19], and ", is a predictive biomarker for m,TextQuoteSelector,TextPositionSelector,14164,14168,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:57:37.701671+00:00
lsqjMrQQEemKxBss5GWHew,3NabqAPM,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1,A novel lncRNA uc.134 represses ,"Wen Ni,1 Yuqin Zhang,1 Zetao Zha",TextQuoteSelector,TextPositionSelector,7028,7117,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:58:15.094742+00:00
lfMniqxGEem4NkPYg15CBA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,drosophila inhibitor of apoptosis 1,"enic inducer 61 (CYR61), c-Myc, "," (diap1), and E2F1, were signifi",TextQuoteSelector,TextPositionSelector,45274,45309,WS_GP,no,WS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:04:37.192198+00:00
lTDsKKxHEemlO3NWuRYmqQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HBV infection,c.134 in HCC may be mediated by ," at the transcriptional level, p",TextQuoteSelector,TextPositionSelector,58913,58926,"WT_OG,DS",no,[WT_OG][DS],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:11:45.407970+00:00
lFW9QKxJEemX_LN_zZnORA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,AFP,tive483414 Positive1198435Serum , (ng/ml)3.8850.037 <25674225 ≥25,TextQuoteSelector,TextPositionSelector,32401,32404,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:26:02.861523+00:00
lF2OIKxFEeml8jOjnZLoKg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,malignancies,(HCC) is one of the most common ," worldwide, and tumor recurrence",TextQuoteSelector,TextPositionSelector,9833,9845,WT_DS,yes,[WT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:57:25.026158+00:00
l29y7KxIEem-hW_YAHU8Jw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,genetic disease,h HCC.Cancer is fundamentally a , with numerous alterations in DN,TextQuoteSelector,TextPositionSelector,52992,53007,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:18:58.540899+00:00
kWFdfrQPEem6_GviTASzgQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 and CUL4A protein in HCC, interaction between endogenous , cells (Fig. 4c). Although a lar,TextQuoteSelector,TextPositionSelector,42385,42415,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:50:56.326986+00:00
kCBSIqxIEemm7uMGexK84w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,tumor progression,"ignaling, which is critical for "," and invasion, is inactivated in",TextQuoteSelector,TextPositionSelector,54047,54064,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:18:46.380634+00:00
jjFGpLQQEemp1s9tCt-_ZQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 were significantly depressed in tumors,d that the expression levels of , compared with adjacent tissues.,TextQuoteSelector,TextPositionSelector,63433,63490,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:58:00.777469+00:00
jH0BuKxFEemTmPt0itqxHg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,infection,hina is hepatitis B virus (HBV) ,", although hepatitis C virus inf",TextQuoteSelector,TextPositionSelector,58484,58493,WS_DS,yes,[WS_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:57:11.659736+00:00
j51heLQsEemZ_HfKnze9lg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,protease,ed in lysis buffer containing a , inhibitor cocktail and RNase in,TextQuoteSelector,TextPositionSelector,24082,24090,WS_GP,no,WS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T07:18:28.738992+00:00
ipdeWKxJEemXtiP1ztyB4Q,3NabqAPM,https://europepmc.org/articles/PMC5395742/,RSRC1,ted in the intron region of the , gene (Fig. 1b) exhibited the gr,TextQuoteSelector,TextPositionSelector,29598,29603,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:25:46.484816+00:00
iiQzxKxEEemugdPPwiCgYQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Myc,r pcDNA3.1(+) with a C-terminal , tag and translated a 87.7-kilod,TextQuoteSelector,TextPositionSelector,25520,25523,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:49:58.477688+00:00
iHyd3qxGEemkFedEDth00A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,TGFβ,"signaling pathways, such as the ","/SMAD, WNT/β-catenin, PI3-kinase",TextQuoteSelector,TextPositionSelector,54283,54287,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:04:14.617741+00:00
hdf0DrQPEemE7xeJoC-Haw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,tumor model by injecting the indicated cells into the tail veins of nude,generated a tail vein xenograft , mice. At the end of the experim,TextQuoteSelector,TextPositionSelector,36403,36475,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:50:37.077035+00:00
hYSHALQQEem0G__rUiFgyg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 expression levels in HCC,panels: HE staining. Figure S7. ," specimens. (A, B) IHC analysis ",TextQuoteSelector,TextPositionSelector,63288,63331,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:57:46.100399+00:00
hGGV-KxJEemkJ1vv2apwHw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,protein A,ith the indicated antibodies on ,/G beads (Life Technologies) ove,TextQuoteSelector,TextPositionSelector,27155,27164,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:25:35.966112+00:00
gaNKrrRMEem_XQdiikLU9A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,MEK,ncreases resistance to RAF- and ,-targeted cancer therapies [41].,TextQuoteSelector,TextPositionSelector,54458,54461,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:07:09.459762+00:00
gU9JYKxIEemJPlsoCVkfwQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,mammals,naling pathway are conserved in , and have a complex network of c,TextQuoteSelector,TextPositionSelector,54182,54189,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:18:21.664743+00:00
gHFDWKxEEem4L38dojx5qg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,mice,er cells into the tail veins of ,. HE staining shows the number a,TextQuoteSelector,TextPositionSelector,63048,63052,CRT_OG,yes,[CRT_OG][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:49:41.968855+00:00
fzdaXKxGEemJOR_zTSTwHg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,SMAD,"ling pathways, such as the TGFβ/",", WNT/β-catenin, PI3-kinase/AKT,",TextQuoteSelector,TextPositionSelector,54288,54292,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:03:59.162267+00:00
fP996KxJEemTris6Q-fRuA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,streptavidin,otinylated RNAs were mixed with , agarose beads (Life Technologie,TextQuoteSelector,TextPositionSelector,24909,24921,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:25:23.670505+00:00
f-4mDKxFEempDyMdul-kOg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,lung metastases,howing the number and volume of , in each group (n=6); **P<0. 01 ,TextQuoteSelector,TextPositionSelector,35413,35428,WT_DS,yes,[WT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:56:50.746620+00:00
eTHfYqxEEem-EldYs-GzvQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,human,", Rockville, MD). The Arraystar ", lncRNA microarray is designed f,TextQuoteSelector,TextPositionSelector,17184,17189,CRT_OG,yes,[CRT_OG][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:49:30.048850+00:00
eLCtJqxIEem09bfsFbD3Kw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,β-catenin,"ays, such as the TGFβ/SMAD, WNT/",", PI3-kinase/AKT, Hedgehog, Jak/",TextQuoteSelector,TextPositionSelector,54298,54307,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:18:07.111576+00:00
drGk_KxJEemX-d_w3-WjYg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,DNase I,nd then treated with RNase-free , (Roche) and 0.2 M EDTA to stop ,TextQuoteSelector,TextPositionSelector,24822,24829,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:25:13.063056+00:00
dq3gCrQQEemLVCttlfyhdA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,"CUL4A, suggesting that it may serve as a tumor suppressor and prognostic biomarker in HCC",po kinase signaling by blocking ,".Go to:Additional files
Addition",TextQuoteSelector,TextPositionSelector,60618,60707,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:57:21.166714+00:00
dWws8KxGEem-HQ92CiN6Qw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,WNT,"athways, such as the TGFβ/SMAD, ","/β-catenin, PI3-kinase/AKT, Hedg",TextQuoteSelector,TextPositionSelector,54294,54297,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:03:42.709575+00:00
dT-66qxFEem-GKuLxCugVg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,RNase,protease inhibitor cocktail and , inhibitor were incubated on ice,TextQuoteSelector,TextPositionSelector,24095,24100,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:56:32.946020+00:00
cha7srQPEemp0p9Ji9kTWA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,tumor model by subcutaneously injecting HCC cells in which uc.134 was stably overexpressed or knocked down into the flanks of nude,"udies, we generated a xenograft ", mice. The overexpression of uc.,TextQuoteSelector,TextPositionSelector,35520,35650,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:50:04.137807+00:00
cIbGmKxEEemX51c6wxIIFA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,tumors,"nks of mice. After 4 weeks, the ", were embedded in paraffin for I,TextQuoteSelector,TextPositionSelector,21852,21858,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:49:15.516329+00:00
bqTHDqxIEemmxzfF-TVVkw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,PI3-kinase,"s the TGFβ/SMAD, WNT/β-catenin, ","/AKT, Hedgehog, Jak/Stat, and No",TextQuoteSelector,TextPositionSelector,54309,54319,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:17:50.347675+00:00
bLJRkqxHEem2c-dXdFUlTg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,hepatitis B virus,risk factor for HCC in China is ," (HBV) infection, although hepat",TextQuoteSelector,TextPositionSelector,58460,58477,WS_OG,no,WS_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:10:37.454355+00:00
bGsBVLQQEemSjddHv-5J2Q,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC by inhibiting CUL4A-mediated ubiquitination of LATS1,4 suppressed the progression of ,. Hippo kinase signaling is high,TextQuoteSelector,TextPositionSelector,59161,59217,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:57:03.877731+00:00
aOKjzKxIEem2d9vPiMwvOQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Stat,", PI3-kinase/AKT, Hedgehog, Jak/",", and Notch pathways [40]. A pre",TextQuoteSelector,TextPositionSelector,54339,54343,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:17:40.474399+00:00
aLTk2rRMEem8nJsszcbbiA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CUL4A, uc.134 (1408–1867 nt) binds to , (592–759 aa region) and inhibit,TextQuoteSelector,TextPositionSelector,11637,11642,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:06:27.552422+00:00
aH5ysKxFEemakh-CQVmhTA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,E2F1,ion of the cell cycle regulator ,", which plays key roles in cell ",TextQuoteSelector,TextPositionSelector,57288,57292,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:56:11.562424+00:00
a50fxKxJEemRJIMS63udHg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,T7 RNA polymerase,in RNA Labeling Mix (Roche) and , (Roche) and then treated with R,TextQuoteSelector,TextPositionSelector,24763,24780,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:24:54.521112+00:00
a4psuqxGEeml9bekcRS8-Q,3NabqAPM,https://europepmc.org/articles/PMC5395742/,AKT,"SMAD, WNT/β-catenin, PI3-kinase/",", Hedgehog, Jak/Stat, and Notch ",TextQuoteSelector,TextPositionSelector,54320,54323,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:03:26.065943+00:00
_WiwdqxEEemP-avcqHl3_w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,c-Myc," angiogenic inducer 61 (CYR61), ",", drosophila inhibitor of apopto",TextQuoteSelector,TextPositionSelector,45267,45272,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:53:11.781489+00:00
ZcWJdKxEEemZLf-q6IB5yQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,cancer,ne of the most common causes of ," mortality worldwide [1, 2]. Cur",TextQuoteSelector,TextPositionSelector,12664,12670,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:48:57.320246+00:00
ZVJiHLRNEem4GOvLPg0kRA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Tumor,)3.8850.037 <25674225 ≥251037924, size (cm)0.0420.487 <51138132 ≥,TextQuoteSelector,TextPositionSelector,32462,32467,MIS_DS,yes,[MIS_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:13:31.470738+00:00
Y9nFhLQQEemp1e940b34TA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 in HCC,of lncRNAs in the regulation of ,". Thus, this lncRNA may offer a ",TextQuoteSelector,TextPositionSelector,58246,58258,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:56:49.738825+00:00
Y2J0PKxHEemX8AM3bvdNIA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HBV, in China is hepatitis B virus (,") infection, although hepatitis ",TextQuoteSelector,TextPositionSelector,58479,58482,WS_OG,no,WS_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:10:21.745460+00:00
Xu4CorQPEemE7rdf3NKNrQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC progression by inhibiting the CUL4A-mediated ubiquitination of LATS1,e novel lncRNA uc.134 represses , and increasing pYAPS127 express,TextQuoteSelector,TextPositionSelector,16676,16748,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:49:31.880953+00:00
Xl7TtqxEEem08vf5gBhTZw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,tumor,"mon malignancies worldwide, and ", recurrence and metastasis are m,TextQuoteSelector,TextPositionSelector,9861,9866,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:48:45.026457+00:00
XgfXdKxIEem4QDd3Wy-xkA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Notch,"se/AKT, Hedgehog, Jak/Stat, and ", pathways [40]. A previous study,TextQuoteSelector,TextPositionSelector,54349,54354,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:17:22.386002+00:00
XaRUBLRMEem7yov-F-d37A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,animal,ed significant.In vivo modelAll , studies were performed with the,TextQuoteSelector,TextPositionSelector,21339,21345,MIS_OG,no,MIS_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:06:08.854890+00:00
WsA7OqxGEemTnc_artv-BA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Hedgehog," WNT/β-catenin, PI3-kinase/AKT, ",", Jak/Stat, and Notch pathways [",TextQuoteSelector,TextPositionSelector,54325,54333,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:02:57.700303+00:00
Wot5CqxFEemZMT-YQv3LWQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,ubiquitin,nt LATS1 contains an N-terminal ,-binding domain that can bind in,TextQuoteSelector,TextPositionSelector,41933,41942,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:55:48.043588+00:00
VwxQXKxJEem4R6NDuk_4Ng,3NabqAPM,https://europepmc.org/articles/PMC5395742/,RNA-Binding Protein,s performed using the Magna RIP , Immunoprecipitation Kit (Millip,TextQuoteSelector,TextPositionSelector,23885,23904,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:24:19.904924+00:00
VIvJWKxIEemX-CPrDLd01w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,NF2,o and ubiquitinating LATS1/2 in ,-mutant tumors in the nucleus [3,TextQuoteSelector,TextPositionSelector,55211,55214,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:17:06.469859+00:00
V1AfiqxEEemOBfsPcuOhGA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1,UL4A-mediated ubiquitination of ,"Wen Ni,1 Yuqin Zhang,1 Zetao Zha",TextQuoteSelector,TextPositionSelector,7112,7117,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:48:32.775609+00:00
UpMraLQPEemzO6vRQosDLQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC cell proliferation and invasion by inhibiting CUL4A to ubiquitinate LATS1,expression of uc.134 suppresses , and increasing pYAPS127 express,TextQuoteSelector,TextPositionSelector,16276,16353,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:49:11.128219+00:00
U5bwsKxGEem_bJc-GVRqUQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,RAF,hat YAP increases resistance to ,- and MEK-targeted cancer therap,TextQuoteSelector,TextPositionSelector,54430,54433,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:02:45.708756+00:00
TipEUqxFEemWGSNnZUJ8wg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,E3 ubiquitin ligase,"ing by inhibiting CRL4DCAF1, an ", of the CRL4 complex [42]. CUL4A,TextQuoteSelector,TextPositionSelector,54759,54778,WS_GP,yes,[WS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:55:27.118756+00:00
TKm-VqxEEemqwEveiWKH9Q,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CUL4A,tion and invasion by inhibiting , to ubiquitinate LATS1 and incre,TextQuoteSelector,TextPositionSelector,16326,16331,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:48:15.366268+00:00
TInFAqxIEemRH8cK9Oi7IQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,vascularization,be involved in tumor growth and ,. Previous reports showed that t,TextQuoteSelector,TextPositionSelector,56573,56588,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:16:52.979292+00:00
T4rz7KxJEemkJRejs37FSg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,β-actin,plified as an internal control. , and U6 were used as cytoplasmic,TextQuoteSelector,TextPositionSelector,23617,23624,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:24:07.508619+00:00
Se5l2rQQEemGOTc0AFwYGg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,"HCC cells with plasmids expressing YAP and those expressing uc.134, the decrease in the mRNA level of CYR61, c-Myc, diap1, and E2F1","ion, when we co-transfected the "," was reversed by YAP, indicating",TextQuoteSelector,TextPositionSelector,57569,57700,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:56:06.146965+00:00
SGbHvKxJEemm8xdN_ejMow,3NabqAPM,https://europepmc.org/articles/PMC5395742/,GAPDH,ucibility of the results. Human , gene was amplified as an intern,TextQuoteSelector,TextPositionSelector,23568,23573,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:23:55.402498+00:00
SEmTEKxHEemODtudHSXBHw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HOXA11,by qRT-PCR in HCC cells. (A) nc-,-86 (B) ENST00000426547 (C) ENST,TextQuoteSelector,TextPositionSelector,61301,61307,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:09:36.135017+00:00
RXDsKKxIEemulCfF6QDyXQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,glioblastoma,ed the invasive activity of the , cells [44]. Inactivation of c-M,TextQuoteSelector,TextPositionSelector,56696,56708,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:16:41.129885+00:00
QlHExKxGEem2bx-W_ZXGXw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Merlin,n. A previous study showed that , activates Hippo kinase signalin,TextQuoteSelector,TextPositionSelector,54691,54697,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:02:16.843488+00:00
QGrDaqxJEemumqMwNRMkzA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,reverse transcriptase,total RNA was performed using a , cDNA synthesis kit (Takara). Th,TextQuoteSelector,TextPositionSelector,23087,23108,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:23:41.989578+00:00
Q6fLrKxBEem-YeeiP6Loqw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC,groundHepatocellular carcinoma (,) is one of the most common mali,TextQuoteSelector,TextPositionSelector,9802,9805,"WT_GP,DS",yes,[WT_GP][DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:26:31.582705+00:00
P1exmqxEEemOA3OVjw1sNg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC,groundHepatocellular carcinoma (,) is one of the most common caus,TextQuoteSelector,TextPositionSelector,12623,12626,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:47:52.877793+00:00
O0v3aqxIEem9Fa_MFEyJuw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,NF90,tastases via the degradation of ," [19], and MEG3 is a predictive ",TextQuoteSelector,TextPositionSelector,14149,14153,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:16:24.130002+00:00
NoK3VKxJEemlQ0tez4MzSQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,animals,lines for the use of laboratory ,. For the subcutaneously injecte,TextQuoteSelector,TextPositionSelector,21692,21699,CRT_OG,no,CRT_OG,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:23:25.476827+00:00
NNWFkqxGEemlN48lMFdkjA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,cullin,ts N-terminus associates with a ,-specific adaptor protein to rec,TextQuoteSelector,TextPositionSelector,54889,54895,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:01:54.109891+00:00
MrZgfKxIEem__i8ecRhhYw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,UFC1,"antation [16, 17]. Furthermore, ", promotes HCC cell proliferation,TextQuoteSelector,TextPositionSelector,13912,13916,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:16:09.642352+00:00
M5DpHqxHEemuLBs_jJ2YLw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,KI67,"expressing uc.134, the level of ", expression was lower than that ,TextQuoteSelector,TextPositionSelector,36188,36192,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:09:01.646170+00:00
LTFinrQQEemWKR_BkZSDzg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,"E2F1, which plays key roles in cell cycle progression and cell differentiation in HCC",ion of the cell cycle regulator ," [48, 49]. We performed microarr",TextQuoteSelector,TextPositionSelector,57288,57373,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:55:18.046219+00:00
LNb2XLQPEem48g9jy-TD5w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma progression by inhibiting the CUL4A-mediated ubiquitination of LATS1,"novel lncRNA, uc.134, represses ", and increasing YAPS127 phosphor,TextQuoteSelector,TextPositionSelector,12066,12159,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:48:07.824424+00:00
KxSV3KxIEem__fumi_z5UA,3NabqAPM,https://europepmc.org/articles/PMC5395742/, tumor ,"eover, MALAT1 is associated with",metastasis and can predict recur,TextQuoteSelector,TextPositionSelector,13816,13823,WS_DS,no,WS_DS,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:15:57.001581+00:00
KwvmQKxHEemamBuyCyl_bQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Hippo kinase,y inhibiting YAP and activating , signaling.Go to:MethodsMicroarr,TextQuoteSelector,TextPositionSelector,16877,16889,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:08:47.422683+00:00
KetDsKxGEem05ieF-zCDLQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,TEAD ,"transcription, YAP binds to the ",complex and elevates the levels ,TextQuoteSelector,TextPositionSelector,56365,56370,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:01:35.820530+00:00
K4bl3KxJEemmyyu52WYXsA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HRP,on with horseradish peroxidase (,)-conjugated anti-DIG antibodies,TextQuoteSelector,TextPositionSelector,20086,20089,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:23:07.069582+00:00
JDp4frQQEemPowffxqUI_g,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Myc via interaction with c-Abl in HCC,e transcriptional activity of c-, [45]. diap1 directly binds to a,TextQuoteSelector,TextPositionSelector,56884,56921,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:55:02.900863+00:00
IgfUPKxHEemuj6PHrL2RuQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,YAP,ion and nuclear localization of , in epithelial malignancies [23–,TextQuoteSelector,TextPositionSelector,14832,14835,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:08:32.283743+00:00
IJDvrqxGEemOC1-aJcJLGg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,c-Abl,y of c-Myc via interaction with , in HCC [45]. diap1 directly bin,TextQuoteSelector,TextPositionSelector,56909,56914,WS_GP,no,WS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:01:20.203702+00:00
HJ94WLQQEem7fCeYrh60_A,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1/2 in NF2-mutant tumors,y binding to and ubiquitinating ," in the nucleus [37]. However, t",TextQuoteSelector,TextPositionSelector,55200,55228,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:54:49.947533+00:00
GPkgjKxFEem04q8tbt9NUQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,cancers,f)CUL4A is amplified in various ,", which suggests its role in reg",TextQuoteSelector,TextPositionSelector,40396,40403,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:53:57.986218+00:00
G3s86KxIEem08ut6I7Z-eQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,MALAT1,"d metastasis [13–15]. Moreover, ", is associated with tumor metast,TextQuoteSelector,TextPositionSelector,13791,13797,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:15:30.699659+00:00
FlISSKxGEemnEH-IhC27Mw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,let-7, classic tumor suppressor miRNA , is also conserved among species,TextQuoteSelector,TextPositionSelector,59373,59378,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:01:03.048052+00:00
FfuzfLQQEemSA2Pbyuz6HA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 is a core kinase of Hippo kinase signaling pathway and plays important roles in tumor,"er, the serine/threonine kinase "," proliferation, apoptosis, and s",TextQuoteSelector,TextPositionSelector,54513,54604,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:54:38.777775+00:00
ERbG7rQQEem_Qnd90IA6mA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CUL4A-Hippo axis may offer a promising approach for the treatment of HCC,"naling. Thus, the lncRNA uc.134-"," (Fig. 6e).
Go to:DiscussionHCC ",TextQuoteSelector,TextPositionSelector,51179,51251,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:54:30.849804+00:00
EL4fjrRNEembMMNZGcoXjw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,serine/threonine kinase,"r therapies [41]. Moreover, the ", LATS1 is a core kinase of Hippo,TextQuoteSelector,TextPositionSelector,54508,54531,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:11:09.460929+00:00
DuCcnKxFEemXoae2oBJTnA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,hepatocellular carcinoma,A novel lncRNA uc.134 represses , progression by inhibiting CUL4A,TextQuoteSelector,TextPositionSelector,7028,7052,CRT_DS,yes,[CRT_DS][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:53:41.110368+00:00
DMTU7qxHEem_-hsBAls-ig,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Dlx-5,e intergenic region between the ," and Dlx-6 genes, activates tran",TextQuoteSelector,TextPositionSelector,14469,14474,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:07:56.531839+00:00
ByDvILQQEemcIHsour2jng,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 are reduced in the HCC,ly show that the expressions of , tissues compared with the adjac,TextQuoteSelector,TextPositionSelector,50417,50458,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:54:14.123183+00:00
BrEe8qxFEemVoF-tr1XFDg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,diap1,phila inhibitor of apoptosis 1 (,"), and E2F1, were significantly ",TextQuoteSelector,TextPositionSelector,45311,45316,CRT_GP,yes,[CRT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:53:27.379230+00:00
BR5ABKxHEemHhCfOmrv4vA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Dlx-6,ic region between the Dlx-5 and ," genes, activates transcriptiona",TextQuoteSelector,TextPositionSelector,14479,14484,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:07:43.720918+00:00
AwdKjqxJEemTqc8zFSr0Gg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,serine/threonine-protein kinase LATS1,"is. By phosphorylating YAP, the ", inhibits the translocation of Y,TextQuoteSelector,TextPositionSelector,15159,15196,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:21:59.161502+00:00
AEAIRLQQEemj4lNhw9QkHg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,HCC patients with low LATS1,The median survival time of the ," expression was 16 months, which",TextQuoteSelector,TextPositionSelector,49628,49655,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:54:02.593485+00:00
9QiYUKxFEemuJodQaX_dZQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LAST1,"ive relationships among uc.134, ",", and pYAPS127 in 90 paraffin-em",TextQuoteSelector,TextPositionSelector,60462,60467,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:00:07.156800+00:00
98EmdrQPEemhy5uUYg-XBA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 was significantly downregulated in the tumor,ang Hospital. The expression of , tissues compared with the adjac,TextQuoteSelector,TextPositionSelector,49309,49359,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:53:48.351863+00:00
8bvYMqxGEem4ODullmubtA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,kinase,y is a highly conserved protein , chain that plays a pivotal role,TextQuoteSelector,TextPositionSelector,15027,15033,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:07:11.024635+00:00
75WKOKxIEem_eOsGd2HJpQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,ubiquitin protein ligase, uc.134 significantly repressed , and RNA polymerase activity com,TextQuoteSelector,TextPositionSelector,41735,41759,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:21:26.333376+00:00
74VldrQPEemaloOz9WMIZg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 or pYAPS127 in 90 paraffin-embedded surgical specimens of HCC, to determine the expression of , from Nanfang Hospital. The expr,TextQuoteSelector,TextPositionSelector,49200,49267,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:53:34.450882+00:00
6mJTeLRMEem9BisiXqsO3w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,polymerase,ISH) and quantitative real-time , chain reaction (qRT-PCR) analys,TextQuoteSelector,TextPositionSelector,10586,10596,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:10:05.250715+00:00
5v735rQPEem-rH9eORAAzw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,"LATS1, and pYAPS127 expression by ISH and IHC in paraffin-embedded samples from patients with HCC","died correlations among uc.134, ", (Fig. 6a). IHC analysis was use,TextQuoteSelector,TextPositionSelector,49038,49135,NGD,no,NGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:53:20.249307+00:00
5jyP2qxEEempCIt_-Pzxnw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,CCK8,o assess data obtained from the , assays and tumor growth. Correl,TextQuoteSelector,TextPositionSelector,27853,27857,WT_GP,yes,[WT_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T05:52:32.876359+00:00
5Y2_xqxGEemN3AMW0DpUlQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,pepsin,", HCC samples were treated with ", for 10 min at room temperature ,TextQuoteSelector,TextPositionSelector,19305,19311,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:06:50.738460+00:00
3uHtOqxIEemJQGchqAwJsw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Mob1,"ippo signaling pathway, such as ",", MST1/2, LATS1, and YAP, wherea",TextQuoteSelector,TextPositionSelector,45139,45143,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:20:58.580802+00:00
3e7ytLQPEemcH0_FNA6Q_Q,3NabqAPM,https://europepmc.org/articles/PMC5395742/,LATS1 and pYAPS127 levels in HCC,sion positively correlates with , patient samplesWe studied corre,TextQuoteSelector,TextPositionSelector,48952,48984,YGD,no,YGD,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T03:53:04.978440+00:00
3Vh6iqxGEem-INfgHyIM-Q,3NabqAPM,https://europepmc.org/articles/PMC5395742/,IgG,nput controls and normal rabbit , controls were assayed simultane,TextQuoteSelector,TextPositionSelector,24519,24522,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:06:37.035459+00:00
1tj_rqxGEemZNefWa24cbw,3NabqAPM,https://europepmc.org/articles/PMC5395742/,EGFP,ormed by cells transfected with ,-LV-shRNA targeting uc.134 were ,TextQuoteSelector,TextPositionSelector,62843,62847,MIS_GP,yes,[MIS_GP][ALL],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:06:26.178532+00:00
16mO9qxIEem4REuE9EDz_w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,MST1,"ignaling pathway, such as Mob1, ","/2, LATS1, and YAP, whereas the ",TextQuoteSelector,TextPositionSelector,45145,45149,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:20:46.153890+00:00
0KG5aKxHEem409ezjK5AAQ,3NabqAPM,https://europepmc.org/articles/PMC5395742/,caspases, directly binds to and inhibits , to suppress apoptosis. Activati,TextQuoteSelector,TextPositionSelector,56965,56973,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:13:24.944746+00:00
0DaOqKxIEemWKqsuR1koDA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,cysteine-rich angiogenic inducer 61,"ls of YAP target genes, such as "," (CYR61), c-Myc, drosophila inhi",TextQuoteSelector,TextPositionSelector,45222,45257,CRT_GP,no,CRT_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:20:33.657008+00:00
-tfxiKxIEemkSvv8MSqaGg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,colon cancer,A to promote the development of , [33]. Although CUL4A is predomi,TextQuoteSelector,TextPositionSelector,40799,40811,CRT_DS,no,CRT_DS,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:21:45.464093+00:00
-mq9uKxGEemkFwNQokNUZA,3NabqAPM,https://europepmc.org/articles/PMC5395742/,Dlx-2,ty by directly interacting with , in a target- and homeodomain-sp,TextQuoteSelector,TextPositionSelector,14556,14561,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:07:25.712913+00:00
-GCy2rRMEem7zQfM3iRnGg,3NabqAPM,https://europepmc.org/articles/PMC5395742/,RNA polymerase,ed ubiquitin protein ligase and , activity compared with the nega,TextQuoteSelector,TextPositionSelector,41783,41797,MIS_GP,no,MIS_GP,,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-08-01T11:10:28.482729+00:00
-E4JCKxHEemToxejqobB9w,3NabqAPM,https://europepmc.org/articles/PMC5395742/,hepatocarcinogenesis,ression plays critical roles in , and metastasis [13–15]. Moreove,TextQuoteSelector,TextPositionSelector,13736,13756,WT_DS,no,[WT_DS],,acct:vaishnavijpai@hypothes.is,A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1.,2019-07-22T06:14:31.544264+00:00
